Mereo BioPharma Group PLC ADR
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
Revenue | $0 | $500 | $0 |
Gross Profit | -1 | 368 | -271 |
EBITDA | -9,815 | -14,294 | -12,437 |
EBIT | -9,869 | -14,592 | -12,707 |
Net Income | -7,024 | -14,616 | -12,887 |
Net Change In Cash | 0 | 500 | 0 |
Free Cash Flow | -7,309 | -7,651 | -8,649 |
Cash | 48,698 | 56,125 | 62,483 |
Basic Shares | 159,989 | 159,887 | 156,855 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $500 | $0 | $10,000 | $1,507 |
Gross Profit | 367 | -1,088 | 7,426 | 257 |
EBITDA | -39,349 | -40,795 | -26,056 | -39,978 |
EBIT | -40,501 | -41,883 | -27,117 | -40,874 |
Net Income | -41,878 | -43,253 | -29,466 | -42,121 |
Net Change In Cash | 500 | 0 | 10,000 | 1,507 |
Free Cash Flow | -30,991 | -33,533 | -21,551 | -48,834 |
Cash | 40,992 | 69,802 | 57,421 | 68,182 |
Basic Shares | 159,423 | 147,924 | 131,890 | 120,639 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.007 |
2025-09-30 | -$0.01 |
2025-06-30 | -$0.02 |
